Evaluation of the efficacy of traditional Chinese medicine on asymptomatic patients infected with COVID-19

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: experimental group:Symptomatic treatment of Western medicine + Jinghua Jiedu decoction;control group:Symptomatic treatment of Western medicine + Jinghua Jiedu decoction placebo; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Nucleic acid turning negative time;Nucleic acid conversion rate; SECONDARY OUTCOME: rate to the light/normal;Time to change to the light/normal;Incidence of symptoms;Cumulative incidence of adverse events; INCLUSION CRITERIA: 1. Asymptomatic patients with COVID‐19; 2. Age 18‐80 years old; 3. Voluntarily accept treatment and sign informed consent.
Epistemonikos ID: d97ff1976d09fac40f7c234ff229d8e120cd43fd
First added on: Jan 14, 2023